This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2 - 4 November 2021
Delivered in GMT time zone

Kai Langel
Director, Janssen Clinical Innovation (JCI) at Janssen-Cilag GmbH, Johnson & Johnson, Belgium

Profile

Since 2000, Kai has been a pioneer in patient-facing solutions for clinical trials working with young innovative technology companies. In 2012, Kai co-founded eClinicalHealth, the developers of the Clinpal remote clinical trial platform. Through his involvement in technical, operational and scientific roles, he has gained an in-depth understanding of all aspects of the patient journey in clinical trials from recruitment and engagement through data capture.

Kai is a Director in the Janssen Clinical Innovation group, working within the digital health team delivering scalable solutions for digital transformation of clinical trials. In his role, Kai leads digital health innovation projects, focusing on decentralized and remote trial methods, remote patient monitoring and digital data capture and endpoints.

Agenda Sessions

  • PANEL: Increasing Efficiency and Reducing Cycle-Times in Drug Development: Multi-Stakeholder Views on the Topic

    11:30
  • The latest on DEEP - Digital Endpoints and Protocols

    10:00